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Chapter I .
INTRODUCTION
Goals of the Study
The purpose of this thesis is to conceive and create a
series of medical illustrations which reflects a descriptive
overview of Rheumatoid Arthritis (RA). Five specific areas
of the disease are investigated: 1.) History, definitions,
variants, statistics, 2.) Morphology, 3.) Etiology and
pathogenesis, 4.) Clinical course, and 5.) Treatment.
The written component of the thesis integrates the
technical literature with the visual material, to provide a
more complete understanding of the origins, current research
models, and implications of this crippling disease.
Five specific goals are designed to guide the research
and illustration process:
1. Maintain conceptual and anatomical accuracy
through-out; maintain aesthetic criteria as
it correlates to complex medical information.
2. Visually communicate the essentials of RA via
a comparison, when possible, to a normal or
non-diseased state.
3. Develop appropriate icons to depict recurring
anatomical structures, i.e., the body, hand,
and generic joint, as primary loci of disease.
4. Create images with and without the benefit
of direct observation; critically use available
resource material to expand a vocabulary of
medical images.
5. Offer the reader generalized information on RA ,
further education and awareness and the central
role a patient can play in his own health care.
History and Development of Medical Illustration
Medical illustration, an ancient profession, Is
inextricably linked to the development of direct
observational techniques that brought medical practice out of
the dark ages of superstition and mistaken adherence to
unproven theory.
The foundations of modern medical science are usually
traced back to two great Italian anatomists: Andreas
Versalius and Leonardo da Vinci. Versalius, whose
masterpiece of 1543, De Humani Corporis Fabrica (O'Malley
and Saunders, 1950), is principally remembered for its
stunning wood block illustrations produced in Titian's
workshop. Prior to Versalius and da Vinci, medical texts
were largely unillust rated , and those plates that did
accompany the text were usually copied from earlier works,
with no reference to the actual dissection of human bodies
(Jansen, 1962). Versalius and his artists, along with da
Vinci, however, strictly adhered to the visual facts that
they could establish through direct observation of cadavers.
In so doing, they demonstrated both the value of original
research and the need for accuracy for effective visual
communication in medical science. Thereafter, during the
16th through 19th centuries, the roles of the
artist/ illustrator and scientist/ phys ician grew dramatically
through the consequent discoveries of the world and of man
himself in nature.
The modern profession of medical and scientific
illustration has far out-grown the Renaissance notions of
artists embellishing a textbook. Max Brodell, in 1911,
migrated from Germany to begin the first school in the United
States at Johns Hopkins University, where the program
continues today. With the rise of new technologies and
information of the 20th and 21st centuries, medical
illustrators now must meet the challenges of the
communications industry for the bio-medical sciences.
The ability to visually interpret information clearly,
concisely, and correctly with technical skills and
creativity, is the process by which art and science is truly
represented as a single expression.
Chapter II.
OVERVIEW OF RHEUMATOLOGY
History and Development
Arthritis is one of the oldest known diseases. Studies
on prehistoric skeletons indicates early close association in
"homo sapiens" (Smith and Jones, 1910). It is a general term
used when the joints themselves are the major seat of the
rheumatic disease. The earliest known example of multiple
arthritis in a fossil vertebrate is in the skeleton of a
platycarpus (a large swimming reptile), which lived about
100,000,000 years ago. This now resides in the Museum of
Natural History at the University of Kansas (Murphy, 1943).
Chronic arthritis of the spine was present in the Ape Man of
2,000,000 years ago as well as in our ancestors, the Java and
Lansing men of 500,000 years ago, and the Egyptian mummies
dating to 8,000 B.C. (Osgood, 1948). The Romans built
extensive baths throughout their empire because of the
prevalence of the disease (Jansen, 1962).
Rheumatism is derived from the Greek work
" rhumatismos"
which designated mucus (catarrah) as an evil humor which was
thought to flow from the brain to the joints and other
portions, producing pain (Hormell, 1940). Since many other
studies (Ragan, 1948; Mikkelsen, 1976) have shown that an
alteration of an important constituent of the joint mucin
(the mucoploy-sacchar ide : hyaluronic acid) actually occurs in
at least some of the 'rheumatic diseases' , the term at long
last may be somewhat appropriate.
The term 'rheumatism' was probably introduced by Galen
in medieval times (Copeman, 1969), but it was Baillou
(1583-1658) who first used the word in its modern sense to
designate it as a form of acute polyarthritis which has no
connection to gout (Baillou, 1643). He was also the first to
regard rheumatism as a clinical entity. (Copeman, 1969)
Today the term 'rheumatic diseases' or 'rheumatology' is used
to cover a large variety of diseases including rheumatic
fever, bursitis, arthritis, gout and other conditions. They
are induced by aging, hereditary and environmental factors
such as physical, chemical, infective, metabolic and
immunologic. These in turn, produce signs and symptoms
referable to the musculoskeletal system and connective
tissue, which cause somatic pain, stiffness and inflammation.
Obviously, the term 'rheumatoid
diseases' has little
pathological meaning, but it does provide a system of
classifying several poorly understood diseases and disorders.
Rheumatiod arthritis (RA) then, is one such condition
or group of conditions. It was first recognized as a
separate disease entity in 1800 by Landre-Beauvais , with a
pathology distinct from gout (Copeman, 1964). However,
Virchow in 1863 called all forms of chronic arthritis
"arthritis deformans" and Charrot also believed they were the
more or less the same disease: ' rheumat isme articulaire
chronique" (Charot, 1889). By 1906, Bannatyne had
successfully further distinguised RA from osteoarthritis
( Copeman , 1964).
The 'renaissance of rheumatology' began shortly after
World War II, when numbers of young physicians who had been
trained in Army Arthritis centers returned to civilian
practice (Copeman, 1969). Due to the founding of the
Arthritis and Rheumatism Foundation (1948), the discovery of
the effects of cortisone on arthritic inflammation (1949),
and the establishment of the National Institute of Arthritis
and Metabolic Diseases (1953), tremendous impetus and focus
was given to RA. The same remarkable growth trend has been
noted in many other countries throughout the world.
Definitions of Rheumatoid Arthritis
Rheumatoid arthritis then, is a major member of a group
of inflammatory system connective tissue diseases ("collegen
diseases"), which includes rheumatic fever, disseminated
lupus erythematosus, polyarthritis, scleroderma, and possibly
other conditions (Lichens tein , 1975). Duthie, a foremost
rheumatologist , defines RA as a "subacute or chronic,
non-suppurative , inflammatory polyarthritis affecting mainly
the peripheral synovial joints, normally in a symmetric
fashion, running a prolonged course of exacerbations and
remissions, and accompanied by signs of systemic disturbance
such as anemia, weight loss and a raised erythrocyte
sedimentation rate" (Duthie, 1969).
Other generalized manifestations include: age of onset
at the third to fourth decade, world wide prevalence of
three-percent, affecting females to males (3:1 ratio), usual
presence of rheumatoid factor (RF), infiltration of
lymphocytes and plasma cells, x-ray findings with erosions
and osteoporsis, subcutaneous nodules (present in 20%), and
end-stage bony or fibrosis ankylosis, and, or amyloidosis
(Huskisson, 1987; Ghadially, 1985; Berens and Lin, 1979).
Variants of Rheumatoid Arthritis
Two varieties of RA merit brief descriptions: Juvenile
Rheumatoid Arthritis (JRA) and Felty's syndrome.
Juvenile RA, or Still's disease is an uncommon,
crippling disease of children which primarily involves the
joints and cervical spine along with enlargement of lymph
nodes, liver and spleen. Children usually test positive for
rheumatoid factor (RF). The peak incidence is between the
ages of one and three years (Robbins and Kumar, 1987);
however the sixteenth birthday is usually considered the
upper age limit for juvenile onset (Calabro, 1979). Unlike
the classic form of RA, 50% of all patients experience
complete remission (Hollander, 1980).
8Felty's syndrome comprises the triad of polyarthritis
(inflammation of several joints together); leukopenia
(abnormal reduction in number of WBC ' s in blood); and
splenomegaly (enlargement of the spleen). This disease
occurs in patients between fourty-five and sixty-five years
of age although has onset many years before detection of the
splenomegly (Zvailfler, 1985). It presents the
manifestations of systemic rheumatoid disease, i.e., high
titers of RF in the serum and subcutaneous nodules, however,
in these patients the hemotologic problems often predominate
the clinical picture. Felty's accounts for less that
five-percent of all cases coming to medical attention
(Mitchel, 1985).
Epidemiology
According to latest estimates derived from numerous
surveys published (Arthritis Foundation, 1985), there are
over 20,100,000 people suffering from some form of arthritis
or related disease in the United States; RA specifically
affects over 2,400,000. The distribution prevalence of
three-percent of the population is world wide with a
consistent female to male ratio of three to one (Hollander,
1980).
Although arthritis cripples a large number of persons
each year, it kills relatively few. There is no other group
of diseases which causes so much suffering by so many for so
long. Because of the tendency to cripple without killing,
arthritis and rheumatism belong at the very top of the list
of chronic diseases from the standpoint of social and
economic importance. National Health Survey figures showed
that 26% of the people with rheumatic disease were at least
partially handicapped, and about 10% were grossly disabled.
Arthritis and rheumatism result in 27,000,000 lost work days
yearly, second only to heart disease as the cause of chronic
limitation of ability to work (Report of National Arthritis
Commission, 1985; Hollander, 1980).
Classification System
Most cases of arthritis (Hench, et.al., 1948) fall into
one of five groups:
Group I: cases caused by a specific infectious
microo rgani sm
Group II: cases that are possibly infectious but
of unproven etiology
*Group III: cases representing degenerative forms
of joint disease
Group IV: cases in which arthritis results from
direct trauma to the joint
Group V: cases of metabolic arthritis (i.e. gout)
In 1963, the American Rheumatism Association (ARA)
approved the terminology of this classification system and is
recommended for general use (Blumberg, Bunim, et.al., 1964).
10
*Group III (degenerative forms of joint disease) will be
the major topic of discussion for this paper.
See Figure 1. Title Panel: Rheumatoid Arthritis
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Chapter III.
MORPHOLOGY
General Descriptions
Rheumatiod arthritis is a systemic disease that can
cause significant damage to many organs, although its most
destructive effects are seen in the joints. Classically, it
is characterized by bilateral symmetric joint involvement,
which principally affects the small joints of the hands, feet
and wrist, large joints of the shoulder, hip joints, elbow;
temporomandibular joint, and sometimes the joints of the
vertebral column. See Figure 2. Primary Disease Sites in the
Body.
Non-articular manifestations (Huskisson and Hail, 1987)
occur in the peri-articular soft tissues, i.e. subcutaneous
nodules, tenosynovitis around hands or wrists, bursitis,
synovial cysts, and muscle wasting. Major organs including
the heart, lung, spleen, eyes, and skin are also target sites
although not as common for disease activity. Vasculitis
(inflammation of the blood vessels), neuropathy (compression
and carpal tunnel syndrome), and osteoporsis and bone
fractures also have been shown correlative to RA.
Clinicians and radiologists alike have focused
particularly on the hands and wrists in RA because of the
early joint involvement, their functional importance, the
13
fairly characteristic appearance of the disease at these
sites, and the ease with which high-quality radiographs of
these thin body parts are obtained (Genant, 1979).
The most common sites of early involvement include the
ulnar styloid, the first through third metacarpophalangeal
joints (Berens and Lin, 1969); see Figure 2. Sites in the
Hands . This schematic representation of the hand illustrates
the most frequent sites of early erosion in RA.
Articular erosions are a form of bone resorption along
the surface of subchondral compact bone. These erosions are
usually preceded by soft-tissue swelling. Erosions generally
begin at the joint margin in the region of the synovial
reflection where the cartilage ends and the capsule inserts
in the "bare" areas (Martel, 1968). Here, as pannus develops
and erodes local cartilage, the underlying cortical and
deeper cancellous bone becomes rarefied and indistinct, and
later focally destroyed, thereby producing the initial
'surface erosion' (Genant, 1979). See: Differential
Diagnosis: Radiology.
Subcutaneous Nodules
Rheumatiod subcutaneous nodules eventually develop in
about one-quarter to one-third of patients (Robbins and
Kumar, 1987), and are often the hallmark of the moderate or
severe stage (Boyle, 1984). These granulomas occur in
14
subcutaneous tissue and tendon, and may also be found in
internal organs such as the heart, lung, and spleen
(Huskisson and Hail, 1987). They are firm, nontender, oval
or rounded masses varying in size from millet seed-like to up
to 2cm in diameter (Robbins and Kumar, 1987). Excision is
the only useful treatment and is usually at least temporarily
successful for the more common nodule; recurrances are very
common (Decker and Plotz, 1979).
They have characteristic histological features (Dieppe,
Bacon, et.al., 1986): a central area of neurosis is
surrounded by mononuclear cells, the macrophages align with
their long axes pointing to the center of the lesion, and
outer layer of fibrous tissue.
Superficial nodules occur over pressure areas, the most
common sites being the ulnar border just below the elbow and
over the Achilles tendon. Small nodules are found only by
careful examination, and are usually hard and attached to the
underlying periosteum. High titers of serum lgM rheumatoid
factor are nearly always found in nodular disease and is
therefore, diagnos t ically important (Dieppe, Bacon, et.al.,
1986).
Stages of Rheumatoid Arthritis
vary wi
Descriptions of the progressive nature of RA slightly
thin the literature. The American Rheumatoid
15
Association (ARA) in 1981, revised the classification of the
anatomical stages of the disease; this standardization of
nomenclature is designed to cat agorically define specific
phases and thereby facilitate disease diagnosis and
management. Noted rheumatologis t s (McCarthy, Duthie,
Ghadially, Copeman, etc.) have also sought to generalize the
essential morphological changes.
For purposes of simplification, the following stages
condense and exemplify the disease's four main stages:
Stage I (Early)
The process begins as a non-specific
inflammatory synovitis characterized by swelling
and hypertrophy of the synviocytes and the
underlying connective tissues. Soft-tissue
swelling, thickening of the affected joint
capsule(s) and slight osteoporsis maybe seen.
However, there is no major damage upon X-ray
examination .
Stage II (Moderate)
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Pannus is essentially a sheet of f ibrovascular
granulation tissue arising from the perichondral
synovial membrane. It is very firmly attached to
the surface of the articular cartilage. It
presents a shaggy surface because of the small
villous projections and adhesions (stretching
across from the opposite joint face) torn during
opening the joint (Ghadially, 1983).
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Stage III (Severe)
The pannus of synovium having destroyed the
articular cartilage now partially fills the joint
cavity, and the erosions have begun into the
sub-chondral bone. X-ray evidence will show
cartilage and bone destruction, in addition to
osteoporsis. Joint deformity, i.e. subluxation,
ulnar deviation or hypertension may be present,
however without fibrous or bony ankylosis. There
is extensive muscle atrophy and ext ra-ar tucular
soft-tissue lesions, i.e. nodules and
t eno-synovi t is may be present.
Stage IV (Terminal)
In the final stage of the disease, the
inflammatory process will subside and fibrous or
bony ankylosis of the joint will end its functional
life. All other criteria of Stage III may also be
present.
Despite the fact that early and late changes in the
joint are wll recognized, this chronic disease shows such
variations in severity and progression, that it is often
difficult or impossible to distinguish from pathological
examination alone the sequence of earlier RA from the heavy
overlay of secondary osteoporsis after the inflammatory
reaction has subsided (Lichtens tein , 1975), or whether the
disease has been present for a few months or many years
(Robbins and Kumar, 1987). Additionally, a number of changes
can occur simultaneously -
Figure 3. Stages of Rheumatoid Arthritis compares a
healthy synovial joint to that of the progressive destruction
within the joint capsule: synovial inflammation, pannus
formation, and subluxation with bone erosion.
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Chapter IV.
ETIOLOGY AND PATHOGENESIS
Theoretical Origins
Almost all definitions of RA emphasize its chronic and
inflammatory nature. These characteristics are immediately
evident on examining the swollen, red, and tender joints of
affected patients and on sampling the fluids that both the
joints (See: Differential Diagnosis: Synovianalysi s ) . The
inflammatory response is considered to be a biological
adaptation to protect the host from a hostile environment; a
prerequisite is that this response be accomplished without
significant injury to the host's own tissue. Therefore, the
inflammation in RA must be considered inappropriate.
What causes this disease and what mechanism(s)
facilitate their introduction into the host? Despite
advances in our understanding of the immunologic processes
leading to articular inflammation and the biochemistry of
connective tissue destruction, the cause of this malady
remains an enigma. It is still not clear whether RA is one
disease with multiple etiologies or a symptom complex
produced by a single causative factor-
Over the years, many theories have been considered and
discarded; therefore the brief discussion that follows will
be limited only to current hypotheses'.
20
Evidence implicating a specific infectious pathogen is
still lacking; researchers have yet to find any bacterial or
viral particles in rheumatoid tissue that would persist as a
stimulus to rheumatoid factor (RF), a unique antibody.
However, much interest has focused on Epstein-Barr Virus
(EBV) in connection with RA. Antibodies directed against an
EBV antigen have been found in the serum of 65-93% of cases
of RA. It is still not known whether EBV injection is an
etiologic or coincidental factor.
Perhaps there is malfunction of the immune system at
some point, i.e. RF producing B and T lymphocytes are not
removed from the circulation during the development of the
immune system. Another possible explanation could come from
genetic origins, i.e., there is a significant association of
RA with tissue type HLA-DR4, which has been reported by
Griffin, et.al., 1984.
However, the "immune-complex theory", which holds that
there is a local and perpetual immune reaction, is considered
to be the most attractive hypothesis for this disease and is
currently widely accepted as causative.
Pathogenesis
Cellular and Immunological Mechanisms
Although the basic cause of RA is not yet defined, the
mechanisms leading to the various pathological effects are
21
better understood. Rheumatoid arthritis arises from the
results of abnormal and detrimental immune system activity
within the body- There is some original and presently
unexplained impetus that results in the formation of what is
known as "rheumatoid factor" (RF), which leads to the
misplaced immune response. Despite extensive research, the
basic cause of the disease remains unknown.
Overall, a synovitis is first seen, followed by a
proliferation of the inflamed tissue into the joint cavity.
The inflammation gradually spreads across the articular
cartilage and into the underlying bone. Eventually,
inflammation subsides, but scar tissue remains. The scar
tissue, plus the interaction of muscles, tendons and
ligaments with the inflamed joints themselves, leads to the
deformation of the infected areas. The result is the
destruction of various joints of the body, expecially the
small joints of the tarsals, carpals, and phalanges
(Ghadially, 1985; Hough and Sokoloff, 1985; Utsinger,
Zvaifler, et.al., 1985).
For purposes of simplification, five stages of
pathogenesis will be considered:
1. initiation of synovitis (presumably by
some etiological RF carried to the joint
via the circulation)
2. subsequent immunological events that
perpetuate the primary inflammatory response
in the synovium
3. the transition reaction into pannus formation
22
4. cartilage and bone destruction, subluxation,
ulnar deviation, nodules, and tenosynovitis
5. fibrous, bony ankylosis
In the initiation stage of RA , an unknown impetus leads
to the formation of rheumatoid factor (RF), by the
coordinated efforts of T and B lymphocytes. RF is a group of
antibodies whose specificity is for a class of molecules that
naturally occurs in the body: Immunoglobin G (IgG). In
general RF is specific for the Fc or constant region of the
IgG molecules; this region is found in all IgG molecules. The
exact antigenic sites in the Fc section of the IgG molecule
have been analyzed and areas in both the Ch2 and Ch3 region
of all subclasses (IgGl, IgG2, IgG4, and to a lesser extent
IgG3) have been identified as the exact antigenic sites
(Kooperman and Schrohenloher , 1985). Thus, benificial,
naturally-occur ing antibody is the target for RF. RF
'
s
themselves are typically IgM proteins, although RF can also
occur as any of the other classes of immunoglobins (IgG, IgD,
IgA, IgE). In general, circulating RF is usually IgM, while
both RF/IgM and RF/IgG are seen in the synovium (Ghadially,
1985; Hough and Sokoloff, 1985; Utsinger, Zvaifler, et.al.,
1985).
Any of these bindings (RF to IgG) is viewed by the body
as an immune complex. In general, the presence of immune
complexes in blood vessels cause platelets and basophils to
release vasoactive amines, which causes complement to be
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fixed and activation of the Hageman factor (Robbins, 1987;
Roitt, Brostoff, et.al., 1985). Vasoactive amines leads to
increased vascular permeability, leading to edema and
allowing the immune complexes to deposit in between the
endothelial cells. Products of complement fixation, C3a and
C5a, also increase vascular permeability (C5a is a
chemotactic factor for neutrophils). Ordinarily, the
neutrophils attach to the antigen-antibody complexes via cell
surface receptors and phagoctyzes and remove the immune
complexes. Neutrophils, however, have great difficulty in
phagocy tosing the immune complexes that have deposited in the
tissue. The result is "frustrated phagocytosis" in which the
neutrophils release their enzyme-containing granules into the
blood stream and onto the endothelium, causing local tissue
damage. Platelets also form microthrombi between the cells,
leading to tissue injury (Robbins, 1987; Roitt, Brostoff,
et.al., 1985). Therefore, a peristance of immune complexes
results and a Type III Hypersensitivity (Immune Complex
Disease) develops (Hough and Sokoloff, 1985; Robbins, 1987;
Roitt, Brostoff, et.al., 1985; Utsinger, Zvaifler, et.al.,
1985). It is also thought that the existence of circulating
RF preceeds synovial involvement (Zvaifler, 1985).
Synovitis results when the attempt to clear immune
complexes occurs in the synovial tissue of a joint. It is
not clear why the small joints of the hands and feet are the
"favored soil" for the disease; possibly RF is in some way
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tissue-specific (Roitt, Brostoff, et.al., 1985). Also, it is
not known whether vasculitis must always preceed synovitis,
but damaged blood vessels in or around the synovium would
allow all the necessary components of inflammation, (i.e.,
the immune complexes, complement, circulating IgG,
neutrophils, RF specific B and T cells, serum proteins, etc.)
to pass easily into the synovium (Ghadially, 1985). Once in
the synovium, RF-specific B cells continue to produce RF, via
the influence of lymphokines produced by RF-specific T cells.
Immune complexes of all varieties (RF/IgM-IgG, RF IgG-IgG)
form in the synovium and in the synovial fluid. These immune
complexes attach to the surface of the synovium and the
frustrated phogocytosis of the neutrophils results in a
"rain"
of destructive enzymes and free oxygen radials onto
the surface of the synovium (Robbins, 1987; Roitt, Brostoff,
et.al., 1985). The destructive molecules are released from
the lysozomes of the neutrophils, which include neutral
proteases that can digest basement membranes, collagen,
elastin, and cartilage. These enzymes can also cleave the C3
and C5 molecules of the complement system, furthering the
generation of C3a and C5a; furthermore, kallikrein is also
released, leading to the formation of bradykinin, a pain
mediator (Robbins, 1987).
In the next stages of the disease, pannus, or
p-ranulation tissue forms in the synovium. Lymphokines from
the RF-specific T cells cause proliferation of the
25
synoviocytes, more RF-specific B and T cells, fibroblasts,
and blood vessels. The result is that the synovium greatly
increases in thickness with its lining cells becoming
elongated and arranged in a palisade fashion. Also, fibrin
is deposited onto the synovial surface, forming a thick cap
in some places, and also in the matrix of the synovium.
Beneath the palisade layer are up to twenty layers of
synoviocytes, sometimes including giant multinucleated cells.
Foci of necrosis do occur, as well as desquamination
(Ghadially, 1985). B and T lymphocytes tend to concentrate
in compact foci around blood vessels. T cells, however, also
migrate throughout the synovial tissue and fluid, while B
cells and plasma cells are relatively immobile, and form the
bulk of the lymphocytes within the granualation tissue
(Boyle, 1984; Ghadially, 1985; Robbins, 1987; Utsinger,
Zvaifler, et.al., 1985).
Once the articular cartilage is covered with pannus, the
inflammatory process erodes the cartilage. The destruction
is most noticeable at the car til age-pannus junction,
resulting in a
"chewed"
appearance (Hough and Sokologg,
1985). As subchondral granulation forms, the adjacent
chondrocytes become necrotic and the articular cartilage
disappears. Using immunohi s tological techniques, immune
complexes and collagenases have been demonstrated in pannus
in these areas. Also, prostaglandins, which are involved in
several aspects of the inflammatory process, have been
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produced when pannus is cultured in vitro (Zvaifler, 1985).
Once collagen has been destroyed, the damage to the articular
cartilage is irreversable (Boyle, 1984; Ghadially, 1985;
Zvaifler, 1985).
Ultimately, erosions begin to appear in the subchondral
bone. Since the subchondral granulation tissue Is continuous
with granulation tissue in the synovium, there is massive
inflammation of the surrounding tissues. Osteoclastic bone
resorption occurs and normal vascular foramina become
enlarged; the bone weakens and the bone marrow also may
become inflamed (Ghadially, 1985; Robbins, 1987).
Eventually, the inflammation subsides, perhaps because most
of the pannus has been replaced by scar tissue and that there
are no cells left to "feed" the infection.
Subluxation results from the result of muscle action
over the altered surfaces and weakened synovial capsules and
ligaments. Tendon contractures and ruptures also can add to
the macroscopic disfigurement and destruction.
Finally fibrosis and in extreme cases bony ankylosis
fuse the joints (Boyle, 1984; Hough and Sokoloff, 1985).
Tendons and ligaments, which are near to the synovial
capsules in small joints may also be similarly damaged.
Pathological Features
Serositis and Vasculitis
The three main pathological features of RA are
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serositis, nodules and vasculitis. Subcutaneous nodules are
discussed in the Morphology section, therefore, a brief
description of vasculitis and serositis completes the
clinical profile.
Vasculitis affects a small proportion of patients with
RA. Inflammation of the walls of small blood vessels may
result in a number of different pathological features. The
most common lesions occur around the nails and may appear
transiently during the phases of active disease. More
persistent vasculitis may result in peripheral ulceration and
even gangreine; characteristic vasculitic ulcers are very
painful (Dieppe, Bacon, et.al., 1986).
Serositis, the inflammation of a serous membrane,
manifests itself in the synovial tissue, tendon sheath, and
bursa, causing synovitis, tendonitis, and bursitis.
Synovitis in RA has features of both chronic and acute
inflammation; it is usually painful, particularly on motion,
and is characterized by a flucuating swelling due to effusion
within the synovial sac (Ghadially, 1985). Synovitis may be
visualized directly by either arthroscopy or at arthrotomy-
Tendonitis and bursitis may also cause destruction and
deformity, leading to joint subluxation, laxity of
periarticular tissues and tendon rupture. Tendonitis is the
inflammation of the tendon and tendon muscle attachments.
Bursitis affects the bursa, the fluid filled cavity located
within the tissue where friction would otherwise develop.
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Together, these two manifestations are associated with the
development of a characteristic set of clinical deformities:
ulnar drift of the fingers, Swan Neck deformities, loss of
finger extension/ flexion , and wrist subluxation. (Boyle,
1984) Figure 4. Normal Joint Architecture, Rheumatoid
Synovi tis illustrates the contrasting changes that may occur
within the RA joint architecture. Such severe features of
the disease may warrant surgical intervention, should drug
therapy prove ineffective. (See: Treatment, Surgery).
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Chapter V.
CLINICAL COURSE
General Description
Although RA is basically a symmetric polyarticular
arthritis, the joint involvement may be connected with
constitutional symptoms such as weakness, malaise, weight
loss, and low grade fever- Many of these conditions result
from the release of IL-1 upon activation of macrophages under
the influence of T cells (Robbins and Kumar, 1987).
The arthritis first begins with aching and stiffness in
the joints, particularly in the morning. Although the small
joints of the hand are usually affected first, other joints
become involved in most cases and sometimes virtually all the
joints of the body are affected. (See Fig 2. Primary Disease
Sites in the Body, Sites in the Hand). As the disease
advances the joints become enlarged, motion is limited, and
complete ankylosis may occur. The fingers may become
completely immobilized in a claw-like position, and in
advanced cases ulnar deviation may result. At this stage of
the disease, anemia is common. Vasculitis may give rise to
chronic leg ulcers, and may even cause infarctions in the
brain, heart, or intestines.
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Classification Criteria
The American Rheumatoid Association (1983) has developed
four categories to classify degrees of RA : classic,
definite, probable, and possible:
Classic RA requires seven of the following criteria; in
criteria 1 through 5, the joint signs or symptoms must be
continuous for at least six weeks; criteria 2 through 6 must
be observed by a physician:
1. Morning stiffness.
2. Pain on motion or tenderness in at least one
joint.
3. Swelling of soft tissue in at least one joint.
4. Swelling of at least one other joint.
5. Symmetrical joint swelling;
6. Subcutaneous nodules over bony prominances.
7. Roentgenographic changes typical of RA (must
include at least bony decalcification localized
to involved joints.
8. Positive agglutination test (demonstration of
rheumatoid factor).
9. Poor mucin precipitate from synovial fluid
(synovianalysis).
10. Characteristic histologic changes in the
synovium with three or more of the following:
a) marked villous hypertrophy
b) proliferation of synovial cells with
palisading
c) marked infiltration of chronic
inflammatory cells (lymphocytes or
plasma cells)
d) deposition of compact fibrin on surface
or inter stitially
e) foci of necrosis
11. Characteristic histologic changes in nodules
showing foci with central zones of cell
necrosis, surrounded by a palisade of
proliferated mononuclear and chronic
inflammatory cell infiltration.
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Definite RA diagnosis requires five of the above
criteria; in criteria 1 through 5, the joint signs or
symptoms must be continuous for at least six weeks.
Probable RA diagnosis requires three of the above
criteria; in at least one of criteria 1 through 5, the joint
signs or symptoms must be continuous for at least six weeks.
Possible RA diagnosis requires two of the following
criteria; total duration of joint symptoms must be at least
three months :
a) Morning stiffness
b) Tenderness or pain on motion for at
least three weeks
c) History of observation of swelling
d) Subcutaneous nodules
e) Elevated sedimentation rate
Classification of Funtional Activity in RA
Class I
Class II:
Class III
Class IV:
Complete funtional capacity with ability to carry
on all usual duties without handicaps.
Funtional capacity adequate to conduct normal
activities despite handicap of discomfort or
limited mobility of one or more joints.
Funtional capacity adequate to perform few or
none of the duties of usual occupation or of
self-care.
Total or almost total incapacitation, with
patient bedridden or confined to wheelchair,
able to perform little or no self-care.
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Clinical Prognosis
Our knowledge of the course of RA comes from many
longitudinal investigations of the disease carried out during
the past fifty years. Notable among the early studies
(Duthie, Brown, et.al., 1964) in Scotland, whose patients
with advanced RA were admitted to teritiary care centers.
Other studies have dealt with defined populations who were
either hospitalized or nonhospi t ali zed . Based on results of
several other major studies, (Mitchell, 1985) makes the
following observations regarding the clinical outcome:
1. A poorer prognosis is likely in patients
who are seroposi t i tve for rheumatoid
factor -
2. Patients with radiographic evidence of
erosions at diagnosis have a poorer
prognosis .
3. Advanced age at study entry was the most
powerful predictor of eventual functional
disability.
4. Women tend to have more chronic and
disabling disease than men.
5. Extra-articular manifestations of
disease, i.e. subcutaneous nodules and
vasculitis correlate with a more severe
course .
6. Delay in treatment and poor intitial
response to treatment have been cited
as pointing to a poor outcome.
However, (Masi, Maldonado-Crocco , et.al., 1986), observe
features that may predict a favorable prognosis and clinical
course. These include disease of short duration, less
swollen upper extremity joints in the early course of the
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disease, initial asymmetric joint involvement, acute onset
under the age of thirty, favorable response to treatment,
male sex, and black race.
Clinical Prognosis Over Time
The clinical course of RA is highly variable. After
approximately ten years, the disease in about half of the
patients becomes stabilized or may even regress. Most of the
remainder pursue a chronic, remitting, relapsing course.
After fifteen to twenty years, approximately ten-percent of
patients become permanently and severely crippled.
Additionally, RA is an important cause of reactive
amyloidosis. This complication develops in five to ten
percent of these patients, particularly those with protracted
severe disease .
Clinical Remissions
Due to the significant number of regressions and
remissions in patients with RA, (Pinals, Masi, and the ARA
Subcommittee, 1981), established the criteria for clinical
remission. For RA to be considered in remission, five or
more of the following requirements must be fulfilled for at
least two consecutive months:
1. Duration of morning stiffness not
exceeding fifteen minutes
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2. No fatigue
3. No joint pain (by history)
4. No joint tenderness or pain on motion
5. No soft tissue swelling in joints or
tendon sheaths
6. Erythrocyte sedimentation rate
(Westergren method) less than
30mm/hour for a female or 20mm/hour
for a male .
To be considered for this designation, a patient must
have met the ARA criteria for classic or definite RA some
time in the past.
The purpose of these criteria is to encourage uniformity
in definition and use of the term 'remission'. The authors
do not attempt to define a total absence of all articular and
extra-articular imflammation and immunologic activity related
to RA.
These criteria are based on data provided by sixty-five
rheumat ologi st s on 275 RA patients considered to be in
complete remission and 269 patients considered to be in
partial remission or to have the disease. The majority of
patients entering the study had received
"remission-inducing"
drugs. Although the inclusion of spontaneous remission was
actively solicited, few such patients were identified. This
may indicate that natural remissions are rare or that such
patients are lost to follow-up by r heumatologis t s .
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Differential Diagnosis
General Descriptions
Prognosis and therapy can only follow with precise
diagnosis, i.e., skillful history taking (symptoms) and
physical examination (signs), with subsequent laboratory
testing, radiology, and a surgical team if indicated.
The purpose of the history and the physical examination,
(McCarthy, 1979) is to classify a patient's problem into
broad categories which represent the primary nature of the
disease. Common symptoms include: stiffness, pain,
weakness, fatigue and emotional depression; common signs
include: swelling, tenderness localized over afflicted
joints, heat and erythema, and bony spurs. Signs and
symptoms, combined with laboratory investigations, (i.e.,
synovianalysis, radiography, and rheumatoid factor
positivity), are critical in diagnosis of RA. Two specific
aspects of differential diagnosis will be discussed in
detail: synovianalysis and radiography.
Synovianalysis
Paracelsus called joint fluid
'synovia' (like egg).
Synovial fluid (synovia) then, is a clear, sticky liquid that
is similar to egg white. The synovium is the tissue lining
the joint space containing the synovia , terminating at the
margin of the articular cartilage, and supported by the dense
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fibrous joint capsule. It is richly supplied with blood
vessels and lymphatics. Synovia is secreted by the
synoviocytes (synovial lining cells). These are normally
arranged in layers one to three cells thick, embedded in
ground substance but with no basement membrane. The synovium
is therefore not a true membrane, but a modified tissue space
(Rodman, Beneck, et.al., 1966).
Much information about various arthritic diseases and
the systemic rheumatic diseases with prominent joint
involvement can be obtained by 'synovianalysis', a term
coined to indicate an analogy with urinalysis. Test types
include routine and special studies (Hollander, Jessar,
et.al., 1961). Routine synovianalysis consists of gross and
microscopic examination to assay: color,
"mucin"
clot,
viscosity, clarity, WBC concentrations, and differential
leukocyte count (Dorland's Illustrated Medical Encyclopedia,
1988). The analysis of joint fluid is an office or bedside
procudure; its function is to divide a given fluid into one
of five groups :
normal
non-inflammatory (Traumic arthrits,
os teoarthri ti s )
inflammatory-immunologic (Systemic
lupus erythematous, RA , and
Reiter's syndrome)
inflammatory-crystalline (Gout,
pseudo-gout )
Group V. inflammatory-infectious (Acute
bacterial arthritis, tubeculous
arthritis)
Group I.
Group II.
Group III.
Group IV.
Synovia may be easily obtained from the
joints by
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needling, a procedure known as ar thocent esis , (puncture of
joint followed by a withdrawal of fluid, usually be suction
through the puncture needle, or puncture and aspiration of a
joint). Aspiration of joints has been used for differential
diagnosis in arthritis as well as provide a means for
effective local treatment in intr a-art icul ar corticosteroid
therapy (Ghadially, 1983).
Figure 5. illustrates via comparison the normal and
rheumatoid synovial joint analysis as would be expected upon
gross and microscopic examination:
Normal Synovianalysis (Group I)
appearance: straw-colored
mucin clo t : good
leukocytes per ml.: <200 (<25%)
viscosity: very high
other features: sugar is 90% of serum level
Rheumatoid Synovianalysis (Group III-inf lammatory-immunologic )
appearance: cloudy, light yellow
mucin clot : poor
leukocytes per ml.: 8,000-20,000 (60-75%)
viscosity : low
other features: low compliment, slightly low sugar
The above values represent combined data from various
reports (Ghadially, 1985).
Radiology
The gross pathologic processes appearing in the
musculoskeletal system in RA are often demonstrable by
radiologic
examination. A specific radiologic diagnosis is
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most often possible, but more importantly, the detection,
evaluation, and assessment of the structural joint
abnormalities can be achieved.
A good radiographic image is essential for the accurate
assessment of subtle skeletal abnormalities. High resolution
magnification radiology (i.e. fine-detail) has proven
particularly valuable in the evaluation of arthritic and
metabolic bone disorders (Jacobs, 1973; Genant, 1979). High
resolution magnification is achieved by optical magnification
of fine-grain film or by direct radiographic magnification
(used for thicker body parts of the central skeleton) (Wicke,
1987). Optical magnification is well established and proven
in the clinical assessment of RA , for they are often of a
better contrast, higher resolution and less background noise.
In a controlled study, fine-detail radiography in patients
with RA significantly improved detection of early erosive
disease. Assessment of soft-tissue swelling was only
modestly improved with high-resolution radiography in
patients with early or minimal RA. These results are of
particular importance in view of the prognostic significance
of the presence of erosive disease in the initial
examination. When pronounced changes were initially present,
the disease tended to run a rapid course, indicating the
early need for more aggressive therapy (Mall, Genant, et.al.,
1981).
In RA , the foremost destruction is to the articular and
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periarticular structures. Any synovial joint of the body may
be involved, but especially the small joints of the hands,
wrists, knees, and feet. The process may begin
asymmetrically, which in time becomes relatively symmetric.
Radiologic manifestations that reflect these gross pathologic
changes in RA are seen in three distinct areas:
1) periarticular soft-tissue, 2) the interosseous cartilage
space, and 3) the sub-chondral bone (McCarthy, 1979).
Soft tissue swelling develops early In the disease and
invariably precedes cartilaginous changes. Swelling results
form the accumulation of joint fluid, synovial proliferation,
and periarticular edema. Radiographically , symmetric uniform
swelling around the joints is easily detected in the small
joints of the hands and wrist. Slight, regional osteoporsis
may be present in the periarticular regions which contain
trabecular bone, (Doi, Genant, et.al., 1976), producing an
irregular, patchy demineralizat ion ; the dominant hand may be
more affected than the non-dominant (Johnson, Hench,
et.al. , 1973).
Articular erosions are the most distinctive radiologic
manifestation of RA , and their radiographic appearance
provides an important parameter for disease activity,
assessment, and therapy. Erosions begin at the joint margins
where pannus also develops and erodes local cartilage.
Together, initial surface erosion results in a characteristic
"dot-dashed"
or serrated appearance of the cortical line
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(Berens, 1979). Narrowing of the interosseous space reflects
cartilage loss. Such narrowing is almost invariably uniform
in a given joint, perhaps reflecting the greater importance
of enzymatic degradation of cartilage rather that direct
erosion by 'pannus'. This involvement is recognized by the
simple loss of distance that separates the articular ends of
the bone when viewed tangentially (Jacobs, 1973). A false
interpretation of narrowing of cartilage may result from
oblique projections (Johnson, Vaughan, et.al., 1973). In
early disease, a comparison of the interosseous space with
that of an adjacent or contralaterally involved joint(s) is
essential .
In late disease, the interosseous space may be quite
irregularly narrowed or widened as a result of the advanced
destruction and fragmentation of sub-chondral bone, and even
the damage to the supporting capsule, ligaments and tendons.
Osteoporsis is replaced by a uniform demineralizat ion ,
disease, immobilization, and in some cases, corticosteroid
therapy can contribute to this generalized state.
Subluxation or eventual dislocation may take place. Bony
ankylosis (abnormal joint fixation), although not prominent
in adult RA does develop in approximately ten-percent of
cases of advanced disease; it primarily involves the small
peripheral joints, especially the carpals and the tarsals
(Mall, Genant, et.al., 1981). Figure 6. Normal Bone Anatomy;
Rheumatoid Bone Anatomy illustrates some of the radiographic
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features found in later stage of RA as compared to a normal
hand. Note the subluxation of the interphalangeal joint of
the thumb, loss of interosseus space in the
metacarpophalangeal joints, with ulnar deviation and
s ubluxat ion .
Clearly then, radiology is a significant imaging
technique in the diagnosis and management of RA. It
correlates gross anatomical structures, (i.e., periarticular
soft-tissue, interosseous cartilage space, and sub-chondral
bone) with density variations of two-dimensional images.
Radiographic data provides a permanent record not only of
destructive joint changes, but also of the reversal of bony
erosions and joint space narrowing; it represents good
evidence that a given therapeutic agent is effective
(McCarthy, 1979).
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Chapter VI.
TREATMENT
General Descriptions
This section will briefly discuss and review some of the
basic modalities that may be used for the initial and total
management of RA. These include a hierarchy of therapies used
in the disease, roughly in the order of their risk-benefit
ratio :
1. patient education
2. physical therapy
3. salicylates
4. non steroidal anti-inflammatory drugs (NSAIDs)
5. slow acting anti-Inflammatory drugs (SAARDs)
6. cytotoxic drugs
7 . steroids
8. intra-ar t icular therapy
9. surgery
Educat ion
Without question, the single most important element in
the management of rheumatoid disease is education of the
patient. Most patients have only a vague notion of RA and
are unaware of the tendancy for their symptoms to remit and
exac erbate spontaneously. Intense anxiety and depression is
commonly found. Additionally, the average patient is often
unaware of the critical role he himself must play. The
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relief of symptoms, preservation of joint function, and a
reasonable lifestyle are three realistic goals that should be
discussed and coordinated between the patient and the
physician (Lightfoot, 1979).
Physical Therapy
Rheumatoid synovitis (early stage) is a chronic,
inflammatory destructive process which, if unchecked,
proceeds to fibrosis of periarticular sof-tissue, limitation
of movement, destruction of articular structures, with
ultimate malalignment, subluxation, and complete loss of
joint function. Thus, physical therapy is intended to 1)
maintain the range of motion, 2) prevent disuse atrophy of
muscle, 3) minimize deformity, 4) provide adequate systemic
rest, and 5) minimize excessive articular trauma, i.e.,
provide local rest. The elements of such a therapy program
should be initiated as soon as the diagnosis is made and
should be monitored by the primary physician (Huskisson,
1987; Flatt, 1984).
Salicylates, NSAIDs, and SAARDs
Since most arthritic diseases are characterized by
inflammation causing tissue injury and loss of function, drug
therapy is directed therefore towards limiting the
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inflammatory process and its consequences. Several major
catagories of antirheumatic drugs are generally recognized;
they differ substantially in their characteristics, mode of
action and clinical effects.
The history of the anti-inflammatory effects of the
NSAIDs, (non-steroidal anti-inflammatory drugs), began
centuries ago with the use of salicylates by Pliny for gout
(Gross, 1948). But it was not until 1964 that aspirin was
shown conclusively to be effective in RA. Fremont-Smith and
Bayles showed decreased ring size, increased range of motion,
and increased grip strength in most of the RA patients whom
they treated (Fremont-Smith and Bayles, 1965). Their
findings have been confirmed, and extended by
placebo-controlled studies using aspirin in doses of 4.0
g/day or more (Broadman, 1967; Calabro , 1970).
Clinically, aspirin and other NSAIDs are effective
analagesics. The action of salicylates is generally
considered to be peripheral in contrast with the central
action of narcotics. They can suppress the induction of
chemically induced pain, i.e. bradykinin, but do not block
the transmission or perception of painful stimuli.
Gas tro-intes tinal bleeding and peptic ulcers are possible
side effect requiring decrease or discontinuation of dosage.
Standard dose of aspirin therefore, depends to some extent on
the therapeutic goals.
The non steroidal anti-inflammatory drugs (NSAIDs) are
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agents that reduce the signs and symptoms of established
inf lammmation within the first few days of administration.
Examples include aspirin, phenylbutazone, indome thacin ,
ibuprofen, fenoprofen, naproxen, and tolmetin. They may be
effective only while blood levels of the drug are sustained;
withdrawal of a NSAID is soon followed by recurrance of the
signs and symptoms of inflammation, although moderated,
chronic inflammatory arthritis often Is not completely
suppressed by an NSAID, and damage to joints continues to
occur during NSAID administration.
Slow acting ant irheumatoid drugs (SAARDs), also called
remission-inducing drugs (RIDs), are a diverse group of
compounds that share a common pattern of clinical response.
Administration of one of these drugs does not result in any
immediate therapeutic benefit, but after weeks or months; the
onset of clinical improvement may be detected. With
continued administration this may eventually result in
complete suppression of some or all disease manifestations.
However, if drug administration is then discontinued, disease
symptoms gradually recur- During a remission induced by a
SAARD, damage to joints and other tissues probably stops,
although it resumes after the drug has been discontinued.
Examples of SAARDs include the organic gold compounds,
anti-malarial drugs, antimetabolites, alkylating agents,
d-penicillamine , and levamisole. It is noteworthy to mention
that all were developed for other indications and then
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applied to the treatment of rheumatic diseases as an
afterthought. Some SAARDs suppress immune responses, and
others have no generally accepted effects on the immune
system.
Corticosteroids
The corticosteroids themselves have some characteristics
of NSAIDs in that they rapidly moderate established
inflammation and do not prevent the progression of joint
damage. On the other hand, high doses of prednisone have
prolonged effects on immunoglobin synthesis, and the
appearance of some drug effects may even be delayed, as in
treatment of vasculitis or nephritis (Paulus and Furst,
1985).
The administration of immunosuppressive drugs to
patients with rheumatic diseases, begun in the last quarter
century, has increased to such an extent that it has now
passed form the investigational to the routine.
Additionally, more recent immunos t imulat ion therapy has
equally been tested and advocated. Thus, we have now
extended our concepts to speak of
' immunoregulatory ' drugs in
the management of RA. However, the advantages and
disadvantages of each drug needs to be considered
individually against the background of the specific degree of
the disease .
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Surgery
There are four major types of operations currently used
on the joints of patients with rheumatoid arthritis:
synovectomy, arthroplasty, osteotomy, and arthrodesis.
Synovectomy is the excision of a synovial membrane, as of the
lining the capsule of the knee joint or of the synovial
sheath of a tendon. Arthroplasty is any operation which
reconstitutes a joint. Osteotomy involves the surgical
cutting of a bone near to a joint but outside the joint
capsule. Arthrodesis involves the surgical fixation of a
joint by a procedure designed to accomplish fusion of the
joint by a promoting the proliferation of bone cells, also
called artificial ankylosis (Mowat, 1979). See Figure 7. The
Arthritic Hand.
Synovectomy , or the removal of part or all of the
synovial lining/membrane of a joint was first used in
rheumatoid arthritis in 1887 by Schiiller following its
beneficial effect in tuberculosis. However, synovectomy was
only undertaken in significant numbers of patients from the
mid-1950's, following promising results when tried in a
variety of joints (Copeman, 1964). At present, the operation
is only considered of value when performed on finger joints,
the wrist, elbow and knee joints (Chase, 1983).
The synovial membranes surrounding the extensor tendons
at the wrist when involved in rheumatoid arthritis, pose a
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threat to the continuing integrity of the extensors. The
extensors pass through tunnels beneath the extensor
retinaculum at the wrist, and at this point tendon direction
changes, creating a need for a pulley-like mechanism. Tendon
gliding within the tunnels is assured by the existence of the
synovium. The inflammation of this synovium in rheumatoid
disease causes swelling, thickening and invasion of the
tendons by inflammatory cells (Scott, 1984).
Clinically, the synovial swelling is evident as it
protrudes both proximal and distal to the extensor
retinaculum. Drug therapy and immobilization may be adequate
to control dorsal tenosynovitis but if it is progressive
despite non-surgical efforts, synovectomy should be
recommended (Chase, 1983).
An example of this condition was surgically observed in
a thirty-eight year-old woman with a five-year history of
rheumatoid arthritis. She had pain over the extensor surface
of her wrist and marked swelling limited to the extensor
tendon area for an area three centimeters distal to the
extensor retinaculum at the wrist. The mass was boggy and
cystic to palpation, and on pressure one could detect
transmission to the area beneath the retinaculum and
proxinmal to it in the forearm. Because of her pain and the
probable threat to the integrity of her extensor tendons,
extensor synovectomy was decided upon (See Figure 8.
Synovectomy) .
52
The procedure was begun with a lazy-S shaped incision on
the dorsum of the hand and wrist, extending proximal and
distal to the extensor retinaculum. The ext r asynovi al
extensor retinaculum was incised at the ulnar border and the
retinaculum was reflected radially. By cutting the partition
between the tunnels close to the bone, the retinaculum was
lifted like a blanket across the wrist. As much of the
hypertrophic synovium as possible was excised, being careful
not to injure the already weakened extensor tendons. The
flap of the extensor retinaculum was replaced beneath the
tendons and the wound was closed. Considerable bow-stringing
of the extensors after this procedure can be anticipated,
however a small sacrifice to save the extensor tendons from
progressive destruction, stretching and rupture. However, it
must be emphasized that synovectomy produces predictable
results in terms of relief of pain and swelling for periods
of three to five years.
A second example of another type of operation used on
patients with RA is tendon transfer- Tendon transfers are
useful in restoring functions of the hand because of
paralysis produced by disease or trauma (Milford, 1988).
Rheumatoid synovitis involving the synovium around the
extensor tendons at the wrist, if left unchecked, may
ultimately result in
destruction of the extensor tendons.
Rupture of extensor tendons is more common than flexor tendon
rupture (Mowat, 1979). Rupture or attenuation and stretching
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of the extensor tendons leaves the patient unable to extend
the metacarpophalangeal joint and robs him of extension
strength at the int erphal angeal joint levels. Diseased and
attenuated tendons are not repairable by repair without
reinforcement. The best method to restore extension
capability is by tendon transfer- Occassionally , one may use
a tendon graft to bridge the area of the weakness in the
extensor, however, it is generally more satisfactory to hook
the distal end of the ruptured tendon into a functioning,
intact extensor by transfer- (See: Figure 9. Tendon
Transfer) .
A fifty-eight year old man with RA with multiple joint
involvement was directly observed in surgery. He had
developed progressive weakness In extension of the long,
ring, and little fingers of the right hand and developed a
finger drop deformity in these fingers. However, he had
excellent strength in the extensor indicis and a transfer of
the extensors of the ulnar three fingers to the indicis was
selected for treatment.
Surgical exploration of the dorsum of the hand revealed
and undiseased, intact extensor digitorum tendon to the index
finger as well as a normal extensor indicis. A side-to-side
juncture of the distal ends of the extensor digitorum tendons
of the long and ring fingers, as well as the tendon of the
extensor digiti minimi, to the extensor digitorum to the
index finger was performed while the three dropped digits
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were held in extension. Pos t-operat ively , the hand was
splinted with the fingers in extension at the
metacarpophalangeal joints and neutral position for the
interphalangeal joints. After a period of six weeks of
splinting, it was predicted that complete extension would not
be restored to the long, ring and little fingers, however the
function would be greatly improved. Independent extension of
the index finger would remain undisturbed.
It must be remembered that the goal of surgery is
fourfold: 1) relieve pain, 2) improve and or restore
function, 3) inhibit progression of disease, and 4) improve
cosmesis (Milford, 1988). When combined with patient
assessment, surgical, and technical considerations, it
usually becomes evident when a patient should be referred for
surgical treatment versus other forms of therapy.
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, SYNOVECTOMY
Extensor Tendons at the Wrist
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TENDON TRANSFER
Rupture of Extensor Tendons
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Chapter VII.
CONCLUSIONS
There now exists a remarkable quantity of information on
this topic. Ample fossil evidence and early writings attest
to its long standing and close association with 'homo
sapiens'. Our current understanding of RA has enabled
rheumatologis ts from around the world to define and develop
systems of classification as well as isolate specific
variants of the disease.
The morphology and its stages have been thoroughly
identified, both macroscopically and histologically, however,
the middle phases are at times difficult to clinically
dis t ingui sh .
Intense research has clarified many of the basic
pathological processes involved in RA, although its
theoretical origins and causes are least understood, despite
recent advances in immunology and biochemistry related to
connective tissue destruction.
Standards of diagnosis and management have grown and
improved enormously, now offering the patient a broad
spectrum of therapeutic modalities. However, we still have
no or little concept of curative treatment or prevention, a
goal which seems unlikely to be achieved for some years to
come .
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Although much data is now available about the cause
epidemiology, pathogenesis, clinical course, and treatment,
their relationship to one another is not clear. Once these
answers are known, it will explain why rheumatoid arthritis
is so common (affecting as many as 1% of all adults), present
in almost all populations, persistent (lasting years to
decades), intimately associated with a unique antibody
(rheumatoid factor), and why it has its particular genetic
constitution (a locus related to HLA-DR4). It is hoped that
the answers will allow us to understand the reasons for
remissions, exacerbations, and the bilateral symmetry of the
arthritis, but more importantly, it should explain the
foremost question, namely, why is rheumatoid arthritis a
disease of the joints?
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APPENDIX I
DESCRIPTION OF ILLUSTRATIONS
General Considerations
The following information corresponds to general
sidelines used in the execution of the illustrations:
1 . Materials and Methods:
Varies within each illustration; see
specific plates for complete production
descript ions .
2. Presentation Factors
a. Matting includes a
3" border on all
colors are of neutral values which
are included within the illustration.
b. Mounting includes in laying
illustrations into matte boards; all
are backed with
1/4" foam-core.
c. Framing is with
3/8" high-chrome mylar
film ( Le traset ) .
d. Exhibition installation of each
illustration is wired from the back
and secured with gaffers tape and
staples .
3 . Typography Specifications
All type is either by transfer or Leroy
lettering system.
a. Titles (excluding Frontis piece) are
set in Microstyle light or bold in
various point sizes.
b. Leroy lettering system in upper/lower
case in sizes from 8-18 point.
c. Leader lines hand ruled, either
dotted or dashed.
4. Ratio and Proportions
All illustrations are sized for 8 l/2"xll",
ll"xl4", used in similar and or different
orientations or multiples of a single format.
Resource Materials
Includes direct observation, anatomy
textbooks, models, X-rays, and photographs
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Figure 1. Title Panel: Rheumatoid Arthritis
Intent of the Illustration: To present the title of the
Thesis In graphic way which acts as a directory for the
color scheme of the art work, matting, and typography.
Each of the horizontal strips correlates to an
illustration in the order in which they are exhibiited.
Materials and Methods: Materials include only the actual
papers and matte boards used in the exhibit; they are glued
and then laminated to foam-core. Complete title was set in
Microstyle Bold (72 pt.), and converted to "Chromatec"
transfer .
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Figure 2. Primary Disease Sites in the Body, Sites in the Hand
gcjrnary Disease Sites in the Body Sites in the Hand
Intent of the Illustration: To present the major disease
sites in the body by use of number positions keyed to a
list of locations; to represent disease sites in the
hand by specifically coloring areas on the bones to
emphasize their important position in origin. Both hand
and body is on a raised thickness to increase
dimensionality.
Materials and Methods: Materials include Stratmore
illustration board, Stratmore plate bristol,
Winsor-Newton water colors, and foam-core. Methods
include airbrush of background, figure, and contour of
hand; bones are rendered in water colors and gouche.
Finally presentation of hand is color-enhanced color
xerox .
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Figure 3. Stages of Rheumatoid Arthritis
Intent of the Illustration: To compare a normal synovial
joint to the progressive stages of the disease, by
emphasizing internal changes within the joint capsule
relational to compact and spongy bone. The four joints
are raised off the surface to increase dimensionality.
Materials and Methods: Materials include gradated Pan-tone
paper, Stratmore bristol, India ink and Winsor-Newton
water colors. Original ink work done 200% larger; final
presentation is a black and white photostat with color
enhanced airbrushed areas to indicate changes of the
synovial fluid .
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Figure 4. Normal Joint Ar chi t ic t ur e , Rheumatoid Synovitis
;^am|
Rheumati
Synovitii
Synovial sheath of teooW
Synovialmembraa
Intent of the Illustration: To contrast the anatomy of
the normal architecture to three of the pathological
features of rheumatoid serositis.
Materials and Methods: Materials include warm and cool
gradated Pan-Tone papers, India ink and Berol color
pencils, Identical positioning of joint and surrounding
structures changes only according to the specific
pathology.
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Figure 5. Normal Joint, Rheumatoid Synovial Joint
***.
Normal Synovial Joint
/III
Rheumatoid Synovial %l|6ihtl
'
Intent of the Illustration: To compare a normal synovial
joint to a diseased synovial joint via values assayed
for in synovianalysis.
Materials and Methods: Materials include Stratmore Plate
Bristol, India ink and Winso r-Newton watercolors.
Original art work done at 150% larger; final
presentation is a black and white photostat with
color-enhanced airbrushed areas in the joint spaces and
syringe .
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Figure 6. Normal Bone Anatomy, Rheumatoid Bone Anatomy
Normal Bone Anatomy
...
'
i; - * !!"
Intent of the Illustration: To contrast
via background
reversal, the normal hand
position and anatomy to that
of a rheumatoid hand.
Emphasis in the RA hand
illustrates some of the classic
radiographic features
commonly found in the
later stages of the disease.
m^p rials and Methods: Materials
include graduated Pan-tone
paper for the rheumatoid hand and
Stratmore bristol for
the normal hand. Both
hands (bones) are airbrushed;
labelling is with LeRoy lettering;
title set at 36pt.,
executed and exhibited at
100%.
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Figure 7. Frontispiece: The Arthritic Hand
Surgical Procedures
THE
ARTHRITIC
HAND
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Intent of the Illustration: To illustrate a combination of
morphological features, i.e. swelling, deformity,
subluxation, rendered in a non-schematic style, to
suggest the
"classic" RA hand which would require
surgical intervention; to layout and design a
corresponding book title with appropriate credits.
Materials and Methods: Materials include Stratmore
Watercolor board, Winsor-Newt on water colors, matte
board and transfer type (Baskerville in various point
sizes). The hand is hand painted; the background is
airbrushed; scale is actual size to a typical hand.
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Figure 8. Synovectomy: Extensor Tendons at the Wrist
. , SYNOVECTOMY
Extensor Tendons at the Wrist
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Intent of the Illustration: To illustrate the surgical
procedure 'synovectomy', i.e., the removal of diseased
synovial membranes located in the dorsum of the hand; to
communicate the basic surgical steps by including
essential anatomical landmarks and techniques used with
involvement of the extensor tendons.
Materials and Methods: Materials include carbon dust, India
ink, colored pencil and pastel on video media paper.
Lettering is with Leroy; title is set in Microstyle 36
point; executed and exhibited actual size.
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Figure 9. Tendon Transfer: Rupture of Extensor Tendon!
TENDON TRANSFER
Hupture of Extensor Tendons
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w%
.
Intent of the Illustration: To illustrate the surgical
procedure 'tendon transfer', i.e., relocation of
diseased tendon(s) into a intact tendon via transfer; to
illustrate the basic steps of the procedure and to
emphasize the before and after of the technique.
Materials and Methods: Materials include carbon dust, india
ink, colored pencil and pastel on video media paper.
Lettering is with Leroy; title is set in Microstyle 36
point; executed and exhibited actual size.
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APPENDIX II
JOURNALS, AGENCIES, ORGANIZATIONS
Principle Rheumatological Journals in English
Acta Rheumatalogica Scandinavica
Annals of Rheumatic Diseases
Arthritis and Rheumatism
Bulletin of Rheumatic Diseases
Journal of Rheumatology
Selected Government and Voluntary Agencies
Arthritis and Rheumatism Council in Great Britain
American Rheumatism Association (ARA)
Arthritis Foundation (U.S.)
Australian Rheumatism Council
Canadian Arthritis and Rheumatism Society
National Arthritis Commission
National Institute of Arthritis and Metabolic Diseases (DHEW)
National and World Organizations
European League Against Rheumatism (EULAR)
La Ligue Internationale contre le Rheumatisme (aka
International League Against Rheumatology (ILAR)
Pan-American League Against Rheumatism (PANLAR)
Southeast Asia and Pacific Area League Against Rheumatism
(SEAPAL)
World Health Organization (WHO)
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